Puumala virus causes a moderate form of haemorrhagic fever with renal syndrome called nephropathia epidemica (NE). Like the Korean haemorrhagic fever caused by Hantaan virus, NE is a generalized infection with signs of multiorgan involvement, the most prominent manifestations being capillary leak and renal failure. The aetiological agent of NE was first discovered in tissue sections of the bank vole, Clethrionomys glareolus (Brummer-Korvenkontio et al., 1980 , 1982 , which is the natural host of the virus. In bank voles the infection is chronic and asymptomatic. The virus has been detected in various vole tissues including lung, spleen, kidney, liver, heart and brain (Yanagihara et al., 1984a) . In man, Puumala virus has been isolated during acute NE from the peripheral blood and lung tissue (see Lundkvist et al., 1991) and recently the viral RNA has been detected in cells of the urinary and respiratory tracts and peripheral mononuclear cells (Grankvist et al., 1992) .
We have now investigated the propagation of Puumala virus in various cell types to identify potential target cells in man. Puumala virus infections have previously been studied in endothelial cells and the Vero E6 (African green monkey kidney tubule) cell line (Yanagihara et al., 1984b (Yanagihara et al., , 1990 Schmaljohn et al., 1985) , which we used as reference. The tested human cell lines from the American Type Culture Collection (ATCC) included liver hepatoblastoma (Hep G2), diploid lung cell (CCD-11Lu), lung carcinoma (A-427), embryonic diploid lung cell (WI-38), kidney adenocarcinoma (A-704), pharynx carcinoma (Detroit 562), epidermoid carcinoma of submaxillary gland (A-253) and neuroblastoma from a metastasis of the supra-orbital area (SK-N-MC). A human neuroblastoma line (SH-SY5Y) was kindly provided by Dr S. P~thlman (Karolinska Institute, Stockholm, Sweden). The primary cells were prepared as follows. Endothelial cells from umbilical cords were obtained by collagenase digestion (Jaffe et al., 1973) . The source of monocytes/ macrophages was peripheral blood leukocyte buffy coat fractions of healthy donors' blood; peripheral blood mononuclear cells were separated by Ficoll Paque (Uppsala, Sweden) centrifugation and culture dishadherent cells were selected. Kidney cells were prepared from kidneys of patients with congenital nephrosis of the Finnish type (CNF) (Holth6fer et al., 1991; Ljungberg et al., 1992) . The cells growing out from the glomeruli were identified using cell type-specific antibodies and lectins (Holth6fer et al., 1990 (Holth6fer et al., , 1991 . Cell cultures from bank vole tissues were started from Puumala virus seronegative colony bank voles. Kidney, lung and spleen tissues were excised, minced and further dispersed with trypsin. All the cells were cultured in commercial culture media supplemented with 10% fetal calf serum. The virus used was the prototype of Puumala virus, the Sotkamo strain (Karabatsos, 1985) which is adapted to Vero E6 cells (Schmaljohn et al., 1985) . The virus inoculum was prepared by collecting the conditioned medium on day 14 post-infection of Vero E6 cell cultures and the passage numbers of the virus were 16 to 17. Confluent cultures of ATCC, SK-N-MC, SH-SY5Y and bank vole cells on a 53 cm 2 dish were infected with 300 ~tl, endothelial on a 2 cm 2 dish with 50 ~tl and primary human kidney cells and monocytes/macrophages on a 0"5 cm 2 dish with 25 ~tl of virus inoculum. The virus was adsorbed for 1 h before the medium was added.
Human cells demonstrated a wide host cell range for Puumala virus: most of the cell lines and all of the primary cells tested were susceptible. Fig. 1 shows the time curves of infection for all of the susceptible cell lines given as percentages of infected cells in the culture. This was determined by immunofluorescence (IF) using acutephase patient serum (Hedman et al., 1991) and antibodies to Puumala virus nucleocapsid protein (Vapalahti et al., 1992) . Examples of IF are shown in Fig. 2 . The infected cells of the established cell lines were subcultured during the experiment with a split ratio of 1:3 to 1:4 except neuroblastoma cells (1 : 12) and samples were taken at each passage (Fig. 1) . To test the effect of cell passaging we compared the rate of spread of infection in unpassaged (Fig. 2a) and passaged (b, c) Vero E6 cells. The 100% infection level was reached at the same rate (by day 9), but the intensity of fluorescence was weaker at that point in the passaged cells (data not shown) and the percentage of infected cells could even be reduced after the next passage (b). The primary cells were grown unpassaged and the culture medium was changed every third day. bilities were for comparison classified as high, moderate, low or resistant (Table 1) . The spread of infection was most efficient in the reference Vero E6 cells (highly sensitive) although slow even in these cells. As indicated in Table 1 kidney cells propagated the virus at a comparable rate whereas vole spleen, lung and all the human primary cells showed a moderate sensitivity. Fig. 1 shows how most of the ATCC cell lines (Detroit 562, A-704, A-253, WI-38 and Hep G2) reached a moderate 80 % level of infection within 17 to 29 days and the maximum level of at least 90 % at later time points. Two of them (A-427 and CCDl lLu) could support only a limited virus growth, less than 5 % became infected and in the two neuronal cell lines (SK-N-MC and SH-SY5Y) no evidence was found for virus propagation (resistant cells). This does not exclude the possibility that higher titres of virus would infect even these cells. If the ceils are passaged the spread of low titre virus in the cultures may not keep pace with the rate of cell division and this could be one reason why resistant cells and cells of moderate to low sensitivity were distinguished in this assay. Three additional tests were used to confirm cell susceptibilities and gave results that were consistent with IF as summarized in Table 1 . Firstly, by Northern analysis accumulation of viral RNA was demonstrated using cDNA probes of the Puumala virus Sotkamo strain S or M segments (Vapalahti et al., 1992) . Secondly the release of virus was investigated in the haemagglutination test Hantaan virus is known to propagate in human peripheral blood lymphocytes (Gu et al., 1989; Yao et al., 1989) and rnacrophages (Nagai et al., 1985) . Since it has been proposed that macrophages may contribute to the spread of Hantaan virus, possibly through an antibody-dependent enhancement (ADE) (Yao et al., 1992) , it is of interest that macrophages also support Puumala virus replication. Susceptibility of the lung-, submaxillary gland-and pharynx-derived cells (CCD-I 1 Lu, A-427, WI-38, A-253, Detroit 562) is in line with the reported sensitivity of A-549 cells (human lung carcinoma) to Hantaan virus (Hamada et al., 1986 ) and the proposed entry of hantaviruses through the respiratory tract. Susceptibility of the Hep G2 hepatoblastoma line suggests that the involvement of liver with elevated transaminases in NE (Lfihdevirta et al., 1984; Settergren et al., 1989) could be a consequence of virus propagation in this organ. Particularly interesting is the susceptibility of kidney cells where the most prominent symptoms of Puumala virus infection arise. All the primary human kidney glomerular cells were equally susceptible (moderately sensitive) and no differences could be seen in susceptibilities of glomerular cells of different origin.
No cytopathic effects were seen in any of the infected cell cultures (Fig. 2) in this study which is consistent with earlier reports (e.g. Arikawa et al., 1985 ; Lee et al., 1989) . This along with the relatively high propagation rate of Puumala virus in kidney cells of an asymptomatic bank vole as compared to all the tested human cells suggests that the virus invasion is not the only pathogenetic mechanism in NE. Factors such as cell-mediated immunity, local production ofcytokines and prostaglandins may play an important role (e.g. Cosgriff, 1991) and differ significantly between man and bank vole.
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